Arrowhead Pharmaceuticals Inc.
ARWR
Market Cap$2.32B
Close$
$-3.98
124.5% downside
Current Fair Value
124.5% downsideOvervalued by 124.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $2.32 Billion |
|---|---|
| Enterprise Value | $2.18 Billion |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-5 |
| Beta | 0.95 |
| Outstanding Shares | 133,363,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -15.3 |
|---|---|
| PEG | 3.89 |
| Price to Sales | 4.06 |
| Price to Book Ratio | 3.24 |
| Enterprise Value to Revenue | 4 |
| Enterprise Value to EBIT | -23.9 |
| Enterprise Value to Net Income | -15 |
| Total Debt to Enterprise | 0.02 |
| Debt to Equity | 0.06 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Arrowhead Pharmaceuticals Inc.
CEO: Christopher Anzalone